Investigative Ophthalmology & Visual Science Cover Image for Volume 59, Issue 9
July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Influence of basement membrane components on the in vitro functionality of hESC-RPE
Author Affiliations & Notes
  • Taina Viheriälä
    BioMediTech, University of Tampere, Tampere, Finland
    BioMediTech, Tampere University of Technology, Tampere, Finland
  • Soile Nymark
    BioMediTech, Tampere University of Technology, Tampere, Finland
  • Teemu Ihalainen
    BioMediTech, University of Tampere, Tampere, Finland
  • Pyry Grönroos
    BioMediTech, University of Tampere, Tampere, Finland
  • Heidi Hongisto
    BioMediTech, University of Tampere, Tampere, Finland
  • Anni Sorkio
    BioMediTech, University of Tampere, Tampere, Finland
  • Heli Skottman
    BioMediTech, University of Tampere, Tampere, Finland
  • Tanja Ilmarinen
    BioMediTech, University of Tampere, Tampere, Finland
  • Footnotes
    Commercial Relationships   Taina Viheriälä, None; Soile Nymark, None; Teemu Ihalainen, None; Pyry Grönroos, None; Heidi Hongisto, None; Anni Sorkio, None; Heli Skottman, None; Tanja Ilmarinen, None
  • Footnotes
    Support  Finnish Cultural Foundation, Emil Aaltonen Foundation, Instrumentarium Science Foundation
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4579. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Taina Viheriälä, Soile Nymark, Teemu Ihalainen, Pyry Grönroos, Heidi Hongisto, Anni Sorkio, Heli Skottman, Tanja Ilmarinen; Influence of basement membrane components on the in vitro functionality of hESC-RPE. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4579.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Transplantation of human pluripotent stem cell (hPSC) derived retinal pigment epithelium (RPE) to treat diseases such as age-related macular degeneration is currently under way. For cell replacement therapy, RPE of uniform quality and consistent level of maturation is required with potential implications to functional cell integration and survival after transplantation. We have previously shown, that RPE basement membrane (BM) proteins, type IV collagen, laminin 521, and nidogen-1, affect the maturation of human embryonic stem cell (hESC) derived RPE. In the present study, we investigated the role of BM proteins to the functionality of the hESC-RPE focusing on the highly important Ca2+ signaling.

Methods : Differentiated hESC-RPE cells were seeded (2 x 105 cells/cm2) on 1 µm polyethylene terephthalate (PET) culture inserts coated with collagen IV or laminin 521 alone, or in combination with and without nidogen-1. Cells were cultured from nine to twelve weeks in serum-free culture conditions after which live-cell Ca2+ imaging experiments and immunolabeling of RPE specific markers and Ca2+ channels were performed. For Ca2+ imaging, Fluo-4-AM was used as an indicator, and both spontaneous Ca2+ activity and responses to 2-minute exposures of 100 µM adenosine triphosphate (ATP) were recorded.

Results : Collagen IV coating alone resulted in a morphologically poor quality epithelium compared to the combination of collagen IV and laminin 521 with and without nidogen-1. Regarding functionality, BM protein coatings had a clear effect on both spontaneous and ATP induced intracellular Ca2+ activity in hESC-RPE. Preliminary results indicated that the use of laminin alone reduces the spontaneous Ca2+ activity, and especially the ability of cells to respond to ATP stimuli. The addition of nidogen-1 to the combination of collagen IV and laminin 521 seemed to increase the intracellular Ca2+ activity.

Conclusions : Collagen IV and laminin 521 are commonly used to coat cell culture surfaces for hESC-RPE. However, these proteins are typically used only individually. Our results indicate that it would be advantageous to combine these BM proteins and use extracellular matrix linker molecules such as nidogen to obtain cells with improved functionality.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×